69 Deep Tech Startups in UK to Watch in 2024
How do we build this list?
Tracking:
Last update to the database: April 9, 2024. See changelog.
Join 23,000+ founders, operators and investors.
Seedtable Score Learn how we calculate it here
We use raw data and human intuition to understand if a company is likely to outsource services like Hiring, Design, Development, etc.
company | score | funding | investors | employees | industries | biz model | city | contact |
---|---|---|---|---|---|---|---|---|
Ethereum-based token streaming platform. |
$5M · Seed | Multicoin Capital, Circle Ventures, Safe | 11 to 50 | Fintech, Deep Tech | B2B, SaaS | London, UK | •••••••••••@superfluid.finance | |
Digital assets central clearing paltform. |
$10M · Seed | GSR, Zodia Custody, LMAX Digital | 1 to 10 | Fintech, Deep Tech | B2B, SaaS | London, UK | •••••••••••@cleartoken.io | |
On-chain asset management infrastructure provider. |
$1M · Pre Seed | 8VC, Mako Trading, Marshland Group | 11 to 50 | Crypto & web3, Deep Tech | B2B, SaaS | London, UK | •••••••••••@quantamm.fi | |
Decentralised trading platform. |
$2M · Pre Seed | Keyrock, Daedalus Angel Syndicate, Re7 Capital | 11 to 50 | Deep Tech, Investing | B2B, SaaS | London, UK | •••••••••••@rho.trading | |
Large language model (LLM) data insights platform. |
$1M · Pre Seed | 500 Emerging Europe, Episode 1 | 1 to 10 | Deep Tech | B2B, SaaS | London, UK | •••••••••••@getsentify.ai | |
Generative engineering platform for physical products. |
$4M · Pre Seed | EQT Ventures, Join Capital | 11 to 50 | Deep Tech, Manufacturing | B2B, SaaS | London, UK | •••••••••••@generative.vision | |
LabGenius is a biopharmaceutical company developing protein therapeutics using a machine learning-driven evolution engine. |
$25M | Kindred Capital, Atomico | 51 to 100 | Health Tech, AI, Biotech, Deep Tech, Machine Learning, Robotics, Manufacturing | B2B | London, UK | •••••••••••@labgeni.us | |
3D human lung model developer. |
$2M · Seed | Pioneer Group, Mercia Asset Management, Midlands Engine Investment Fund | 11 to 50 | Biotech, Deep Tech | London, UK | •••••••••••@immuone.com | ||
Tropic Biosciences is a pioneering leader in the development of novel high-performing commercial tropical crop varieties and traits. |
$28M · Series B | Future Planet Capital | 11 to 50 | Agritech, Biotech, Deep Tech, Manufacturing | B2B | London, UK | •••••••••••@tropicbioscience.com | |
Blockchain infrastructure and tooling platform. |
$2M · Seed | Klaytn, NexusOne, Gate.io | 11 to 50 | Crypto & web3, Deep Tech | B2B, SaaS | London, UK | •••••••••••@kanalabs.io | |
Myricx Pharma is a drug discovery company focused on developing small molecule inhibitors. |
$6M · Seed | Sofinnova Partners | 1 to 10 | Health Tech, Biotech, Deep Tech, Pharma | B2B | London, UK | •••••••••••@myricxpharma.com | |
Protein discovery research and manufacturing. |
$19M · Series A | SYSTEMIQ | 11 to 50 | Biotech, Deep Tech | London, UK | •••••••••••@basecamp-research.com | ||
OS for electricity grids. |
$10M · Series B | Clean Growth Fund, Future Energy Ventures | 11 to 50 | Climate Tech & Green Tech, Deep Tech, Energy & Nuclear | B2B, Marketplace | London, UK | •••••••••••@piclo.energy | |
Humanising Autonomy is building the global standard for human machine interactions. |
$5M · Seed | Anthemis | 11 to 50 | AI, Deep Tech, Proptech & Real Estate, Machine Learning, Music and Audio, Data and Analytics, Mobility & Transportation | B2B | London, UK | •••••••••••@humanisingautonomy.com | |
Intelligent test automation. |
$6M · Series A | YFM Equity Partners | 11 to 50 | Deep Tech | London, UK | •••••••••••@automatepro.com | ||
Perfect Ward is the health and quality inspection solution. |
$5M · Series A | octopus investments | 11 to 50 | Health Tech, Deep Tech, Robotics, Manufacturing | B2B, SaaS | London, UK | •••••••••••@perfectward.com | |
Karakuri is revolutionising Quick Service (QSR) and Fast Casual restaurants with intelligent, robotic kitchen automation. |
$8M · Seed | Hoxton Ventures, Firstminute Capital | 11 to 50 | Foodtech, Deep Tech, Machine Learning, Robotics, Manufacturing | B2B | London, UK | •••••••••••@karakuri.com | |
Silicon-oxide based RRAM technologies. |
$8M · Series A | Octopus Ventures | 1 to 10 | Deep Tech, Semiconductor | London, UK | •••••••••••@intrinsicsemi.com | ||
BotsAndUs captures real-time insights of warehouse operations using fully autonomous robots and Artificial Intelligence. |
$6M | Kindred Capital, Lakestar, Capnamic Ventures | 11 to 50 | AI, Deep Tech, Data and Analytics, Robotics, Manufacturing, Ecommerce | B2C, SaaS | London, UK | •••••••••••@botsandus.com | |
SLAMcore provides location, mapping and perception software for robots and other autonomous machines to become spatially intelligent |
$5M | Octopus Ventures, MMC Ventures, Amadeus Capital | 11 to 50 | AI, AR / VR, Deep Tech, Drones, Data and Analytics, Robotics, Manufacturing | B2B, SaaS | London, UK | •••••••••••@slamcore.com | |
Flexciton is the intelligent advantage platform for streamlined chipmaking |
$3M · Seed | BACKED VC, Entrepreneur First, Join Capital | 11 to 50 | AI, Deep Tech, Machine Learning, Manufacturing, Semiconductor | B2B | London, UK | •••••••••••@flexciton.com | |
Immuno-oncology company treats cancer with antibodies. |
$2M · Series A | AlbionVC, Epidarex Capital, Novartis Venture Fund | 11 to 50 | Health Tech, Biotech, Deep Tech, Pharma, Manufacturing, Genetics | B2B | London, UK | •••••••••••@epsilogen.com | |
Ordinals infrastructure paltform for developers. |
$1M · Seed | Kestrel 0x1, Lightning Ventures, Bitcoin Frontier Fund | 1 to 10 | Crypto & web3, Deep Tech | B2B | London, UK | •••••••••••@ordinalsbot.com | |
Brytlyt is a young and dynamic company with a clear mission – to empower organisations through transformational data analytics. |
$4M | AlbionVC, Finch Capital, Amadeus Capital | 11 to 50 | Hardware, Deep Tech, Data and Analytics, Business Intelligence | B2B, SaaS | London, UK | •••••••••••@brytlyt.com | |
Puraffinity develops precision materials to target chemicals, with an initial focus on PFAS in water |
$3M · Seed | Kindred Capital, Verve Ventures | 11 to 50 | Climate Tech & Green Tech, Health Tech, Biotech, Deep Tech, Energy & Nuclear, Manufacturing | B2B | London, UK | •••••••••••@puraffinity.com | |
Foodsteps is a london-based startup that has developed a platform to help the food sector reduce its carbon footprint. |
$4M | Octopus Ventures, Ascension Ventures, Metaplanet Holdings | 11 to 50 | Climate Tech & Green Tech, Health Tech, Agritech, Foodtech, Biotech, Deep Tech, Energy & Nuclear, Business Intelligence | B2B, SaaS | London, UK | •••••••••••@foodsteps.earth | |
7bridges is an AI-powered optimization engine for businesses to scale and automate logistics and supply chains. |
$3M · Seed | Local Globe, Crane Venture Partners, Eight Roads Ventures | 11 to 50 | AI, Deep Tech, Data and Analytics | B2B, SaaS | London, UK | •••••••••••@the7bridges.com | |
Neurovalens delivers innovative solutions in the field of neuroscience, bioscience and neurophysiology |
$2M · Seed | IQ Capital Partners, Techstart Ventures | 1 to 10 | Health Tech, Hardware, Biotech, Deep Tech, Manufacturing, Wearables | B2B | Belfast, UK | •••••••••••@neurovalens.com | |
Nuntius Therapeutics is pioneering a new class of targeted RNA, DNA and CRISPR therapies. |
$125k · Pre Seed | Y Combinator | 1 to 10 | Health Tech, Biotech, Deep Tech | B2B | London, UK | •••••••••••@nuntiustx.com | |
Syrona Health is a personalised digital health platform for Chronic Gynaecological/Uterine Conditions like Endometriosis, PCOS etc. |
$253k · Seed | Y Combinator, Katapult Accelerator | 1 to 10 | Health Tech, Biotech, Deep Tech, Femtech, Ecommerce, ElderTech, Fertility | B2B | London, UK | •••••••••••@syronahealth.com | |
One lab management platform that brings people, equipment and data together - no matter where they are. |
$1M | Forward Partners | 11 to 50 | Health Tech, Biotech, Deep Tech | B2B, SaaS | London, UK | •••••••••••@clustermarket.com | |
Decentralised AI training and finetuning platform. |
$2M · Pre Seed | Tagus Capital, Lightspeed Faction | 1 to 10 | AI, Deep Tech | B2B, SaaS | London, UK | •••••••••••@flock.io | |
Bluezone Insurance offers personalized, same-day life cover for people with chronic conditions, like type 2 diabetes and heart diseases. |
$1M · Seed | Insurtech Gateway, Portfolio Ventures | 1 to 10 | Health Tech, Fintech, Biotech, Deep Tech, Insuretech | B2C | London, UK | •••••••••••@bluezoneinsurance.co.uk | |
Exogene is a biotechnology company accelerating target & TCR discovery for cancer cell therapies using AI-enabled TCR-antigen screening. |
$104k · Pre Seed | Atomico, Entrepreneur First | 1 to 10 | Health Tech, AI, Biotech, Deep Tech, Pharma, Data and Analytics | B2B | London, UK | •••••••••••@exogene.co.uk | |
Mindstep towards better better brain health. |
$450k · Pre Seed | Octopus Ventures, Calm/Storm Ventures | 11 to 50 | Health Tech, Hardware, Deep Tech, Mobile, Business Intelligence | B2B, B2C | London, UK | •••••••••••@letsmindstep.com | |
Synthetic data cloud platform. |
$290k · Pre Seed | Edge VC, High-Tech Gründerfonds, Cogito Capital Partners | 11 to 50 | Deep Tech, Data and Analytics | B2B, SaaS | London, UK | •••••••••••@skyengine.ai | |
Transforming mental healthcare by unlocking the power of clinical data |
$52M · Series B | Molten Ventures | 101 to 250 | Health Tech, Deep Tech | B2B, B2C | Cambridge, UK | •••••••••••@iesogroup.com | |
ONI is a pioneer of super-resolution microscopy, making this advanced technology accessible to new generations of researchers. |
$75M · Series B | Axon Ventures, Oxford Science Enterprises | 51 to 100 | Health Tech, Biotech, Deep Tech, Robotics, Manufacturing, Developer Tools | B2B | Oxford, UK | •••••••••••@oni.bio | |
Lab-quality diagnostics for anyone, anywhere, at any time. |
$85M | Oxford Science Enterprises | 51 to 100 | Health Tech, Biotech, Deep Tech, Pharma | B2B | Oxford, UK | •••••••••••@oslerdiagnostics.com | |
Software for autonomous vehicles. |
$140M · Series C | Kiko Ventures, Business Growth Fund | 251 to 500 | AI, Deep Tech, Machine Learning, Music and Audio, Mobility & Transportation | B2B, SaaS | Oxford, UK | •••••••••••@oxbotica.ai | |
Arrival is a developer and manufacturer of zero-emission, public transportation vehicles. |
$111M · Series A | 1001 to 5000 | Climate Tech & Green Tech, Hardware, Deep Tech, Music and Audio, Mobility & Transportation, Manufacturing, Electric Vehicles | B2B | London, UK | •••••••••••@arrival.com | ||
MiroBio is Harnessing the natural control mechanisms of the immune system. |
$97M · Series B | Medicxi, Oxford Science Enterprises | 1 to 10 | Health Tech, Biotech, Deep Tech | B2B | Oxford, UK | •••••••••••@mirobio.com | |
Microbiotica is a developer of human microbiome therapeutics intended to discover and develop live bacterial therapeutics and biomarkers. |
$66M | Seventure Partners, Cambridge Innovation Capital | 11 to 50 | Health Tech, Biotech, Deep Tech, Manufacturing | B2B | Cambridge, UK | •••••••••••@microbiotica.com | |
Immunotherapy for bladder cancer. |
$30M · Series B | 11 to 50 | Health Tech, Biotech, Deep Tech | London, UK | •••••••••••@prokarium.com | |||
Synthace is a Life Sciences R&D cloud platform that enables experiments to be automated, with the resultant data seamlessly integrated. |
N/A | Sofinnova Partners | 11 to 50 | Health Tech, Biotech, Deep Tech, Pharma, Manufacturing, Internet of Things | B2B, SaaS | London, UK | •••••••••••@synthace.com | |
CoMind is a noninvasive neural technology company building next-generation neural interfaces. |
N/A | Entrepreneur First | 1 to 10 | Health Tech, Hardware, AI, Deep Tech, Machine Learning, Data and Analytics, Business Intelligence | B2B, SaaS | London, UK | •••••••••••@comind.io | |
Pheon Therapeutics is an Antibody-Drug Conjugate (ADC) specialist that creates ADCs for a variety of difficult-to-treat cancers. |
N/A | Forbion Capital Partners | 11 to 50 | Health Tech, Biotech, Deep Tech, Pharma | B2B | London, UK | •••••••••••@pheontx.com | |
Neurofenix is aiming to make rehabilitation more autonomous, enjoyable and accessible to stroke victims. |
N/A | AlbionVC, InHealth Ventures | 1 to 10 | Health Tech, Hardware, Deep Tech, Music and Audio, Mobility & Transportation, Manufacturing, Service Industry | B2B | London, UK | •••••••••••@neurofenix.com | |
Seyo is the trading name of Seyo Limited a company registered (Company Number: 11701852) in England and Wales. |
N/A | Entrepreneur First, 7percent Ventures, Ascension Ventures | 1 to 10 | Deep Tech, Robotics, Manufacturing | B2B, SaaS | London, UK | •••••••••••@seyo.io | |
MiNA Therapeutics is a clinical-stage biotechnology company developing therapeutic medicines to harness gene activation mechanisms. |
$29M | 11 to 50 | Health Tech, Biotech, Deep Tech, Pharma, Genetics | B2B | London, UK | •••••••••••@minatx.com | ||
Cancer diagnostics. |
$16M · Series A | Business Growth Fund | 51 to 100 | Health Tech, Deep Tech | Cambridge, UK | •••••••••••@cyted.ai | ||
Nuclera makes biology accessible through desktop enzymatic protein and gene synthesis. |
$42M · Series B | Future Planet Capital, Amadeus Capital, Verve Ventures | 11 to 50 | Biotech, Deep Tech, Manufacturing | B2B | Cambridge, UK | •••••••••••@nuclera.com | |
Supplant is a biotechnology platform that makes sugar substitutes. |
$24M | Khosla Ventures, Felicis Ventures, Y Combinator | 11 to 50 | Health Tech, Foodtech, Deep Tech, Manufacturing | B2B | Cambridge, UK | •••••••••••@supplant.com | |
Polymateria is a London-based startup advancing science to help nature deal with plastic pollution. |
$18M | 11 to 50 | Climate Tech & Green Tech, Health Tech, Biotech, Deep Tech, Energy & Nuclear, Manufacturing | B2B | London, UK | •••••••••••@polymateria.com | ||
SenSat simulates reality in real time, which helps computers solve real world problems. |
$10M | 51 to 100 | Deep Tech, Data and Analytics, Privacy and Security, Manufacturing | B2B, SaaS | London, UK | •••••••••••@sensat.co.uk | ||
Manufacturer of deployable antennas for spacecraft. |
$3M · Seed | UK Innovation & Science Seed Fund | 11 to 50 | Deep Tech, Space Tech | Oxford, UK | •••••••••••@oxford.space | ||
Bit.bio specializes in the fields of coding and biology that determine the identity of every human cell. |
$41M · Series A | Metaplanet Holdings, BlueYard Capital | 101 to 250 | Health Tech, Biotech, Deep Tech, Business Intelligence | B2B | Cambridge, UK | •••••••••••@bit.bio | |
Mogrify® will transform the development of ex vivo cell therapies and pioneer a new class of in vivo reprogramming therapies. |
$10M · Series A | Astellas Venture Management, Ahren Innovation Capital, Parkwalk Advisors | 101 to 250 | Health Tech, Biotech, Deep Tech | B2B | Cambridge, UK | •••••••••••@mogrify.co.uk | |
Metrion Biosciences is a Contract Research Organization. |
$4M · Series A | Gresham House Ventures, NPIF Maven Equity Finance | 11 to 50 | Health Tech, Deep Tech | Cambridge, UK | •••••••••••@metrionbiosciences.com | ||
Finboot is the dynamic company behind MARCO, a unique blockchain agnostic, enterprise grade SaaS product. |
$3M | 11 to 50 | Fintech, Crypto & web3, Deep Tech, Media and Entertainement, Manufacturing, Supply Chain & Logistics | B2B, SaaS | London, UK | •••••••••••@finboot.com | ||
Virax Biolabs is an innovative Biotechnology company focused on the prevention, detection and diagnosis of viral diseases |
$3M | 11 to 50 | Health Tech, Deep Tech | London, UK | •••••••••••@viraxbiolabs.com | |||
Keelvar offers advanced sourcing optimization and intelligent sourcing automation software. |
$18M · Series A | 83North, Mosaic Ventures, Paua Ventures | 101 to 250 | Deep Tech, Robotics, Manufacturing, Supply Chain & Logistics, IT Management | B2B, SaaS | Cork, UK | •••••••••••@keelvar.com | |
PetMedix is a pet therapeutics startup. |
$13M · Series A | Cambridge Innovation Capital, Parkwalk Advisors | 1 to 10 | Health Tech, Biotech, Deep Tech, Pharma | B2B | Cambridge, UK | •••••••••••@petmedix.co.uk | |
Supplier of configurable process node agnostic analog IP building blocks. |
$5M · Seed | Omers Ventures, Firstminute Capital, MMC Ventures | 11 to 50 | Deep Tech, Manufacturing, Semiconductor | B2B | Cambridge, UK | •••••••••••@agileanalog.com | |
Manufacturer of growth factor proteins for stem cell, organoid and cellular agriculture applications. |
$5M · Series B | Parkwalk Advisors, Downing Ventures | 11 to 50 | Biotech, Deep Tech | Cambridge, UK | •••••••••••@qkine.com | ||
Biorelate provides biomedical research services. |
$7M | Triple Point Ventures | 11 to 50 | Health Tech, Biotech, Deep Tech, Data and Analytics | Manchester, UK | •••••••••••@biorelate.com | ||
Epitopea is a transatlantic cancer immunotherapeutics company. |
$13M · Seed | Cambridge Innovation Capital | 1 to 10 | Health Tech, Biotech, Deep Tech, Pharma | B2B | Cambridge, UK | •••••••••••@epitopea.com | |
Mestag Therapeutics is a biotechnology company that develops new therapies for diseases using fibroblast technology. |
$11M · Seed | GV, Forbion Capital Partners | 1 to 10 | Health Tech, Biotech, Deep Tech, Manufacturing | B2B | Cambridge, UK | •••••••••••@mestagtx.com | |
A synthetic antibody company based in East Midlands, UK. |
$6M | Calculus Capital, Business Growth Fund | 1 to 10 | Health Tech, Biotech, Deep Tech, Manufacturing | B2B, B2C, SaaS | Leicester, UK | •••••••••••@mip-dx.com |
Sign up to access our full database
Enter your email and get access to 17,000+ technology companies you can partner with.